VERACYTE, INC.
6000 Shoreline Court, Suite 300
South San Francisco, California 94080
May 9, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Ronald E. Alper
Re: Veracyte, Inc. Registration Statement on Form S-3 (File No. 333-224576) filed May 1, 2018.
Ladies and Gentlemen:
Requested Date: May 11, 2018
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Veracyte, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission.
The Registrant hereby authorizes Robert Freedman or Ran Ben-Tzur, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Ben-Tzur at (650) 335-7613 or, in his absence, to Mr. Freedman at (650) 335-7292.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
Sincerely, | ||
VERACYTE, INC. | ||
By: | /s/ Keith Kennedy | |
Keith Kennedy | ||
Chief Financial Officer | ||
cc: | Bonnie H. Anderson, Chairman and Chief Executive Officer |
Veracyte, Inc.
Douglas N. Cogen, Esq.
Robert A. Freedman, Esq.
Ran D. Ben-Tzur, Esq.
Fenwick & West LLP